Teijin Pharma and Aska Pharmaceutical have teamed up on small-molecule drugs research for gynaecological diseases, combining AI-led design with clinical tests. The collaboration pairs Teijin Pharma’s...
Almost 80 per cent of private weight loss jabs such as Mounjaro are prescribed to women, according to analysis of 113,630 patients. The analysis, covering private...
Harmful bacteria may worsen breast cancer by switching on an enzyme that damages DNA and helps tumours grow, researchers say. The study found that pathogenic bacteria...
WHIS, the flagship summit uniting leaders across the women’s health and healthcare innovation ecosystem, has just announced that the 2026 edition of the event will be...
A 556-gene signature in the uterine lining may help explain why some embryo transfers fail, even when clinics use chromosomally normal embryos, new research suggests. Even...
Nighttime temperatures during pregnancy may be linked to a higher chance of an autism diagnosis in children, a recent study suggests. The research tracked nearly 295,000...
The World Health Organization (WHO) welcomed a delegation of parliamentarians to its Geneva headquarters for a high-level dialogue on women’s health and sexual and reproductive health...
Agilent has FDA approval for a test to identify ovarian cancer patients who may be eligible for immunotherapy. Agilent’s PD-L1 IHC 22C3 pharmDx is the only...
Transdermal HRT best protects bone density in women with functional hypothalamic amenorrhoea, a condition that stops periods, a review of trials has found. The meta-analysis pooled...
An AI tool cut interval breast cancers by 12 per cent in a Swedish screening trial of more than 105,000 women. The study also found 27...
